In vitro susceptibilities of zygomycetes to conventional and new antifungals

被引:231
作者
Dannaoui, E
Meletiadis, J
Mouton, JW
Meis, JFGM
Verweij, PE
机构
[1] Univ Med Ctr St Radboud, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands
[2] Canisius Wilhelmina Hosp, NL-6500 GS Nijmegen, Netherlands
关键词
D O I
10.1093/jac/dkg020
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In vitro susceptibilities of 36 zygomycete isolates, belonging to six genera, to itraconazole, posaconazole, voriconazole, terbinafine, amphotericin B and 5-fluorocytosine were determined by using a broth microdilution adaptation of the National Committee for Clinical Laboratory Standards M-38P reference method. The influence of incubation time on MIC values, and the performance of a spectrophotometric method for MIC determination in comparison with the visual reference method, were also evaluated. Amphotericin B was active against most of the isolates. All the isolates were highly resistant to 5-fluorocytosine (MICs > 256 mg/L). Voriconazole was significantly less active than the other drugs with an overall MIC90 (MIC at which 90% of the isolates were inhibited) of 32 mg/L. In contrast, posaconazole showed good activity (MIC90 1 mg/L). A wide range of MICs, from 0.03 to greater than or equal to32 mg/L, was obtained for itraconazole and terbinafine. Differences in susceptibility between and within genera were noted. Rhizopus spp. were significantly less susceptible to itraconazole, posaconazole, terbinafine and amphotericin B than Absidia spp., and less susceptible than Mucor spp. to amphotericin B. Terbinafine appeared to be more active against Rhizopus microsporus than against Rhizopus oryzae (geometric mean MIC of 0.15 and 64 mg/L, respectively). The activity of the drugs was dependent on the incubation period. A significant increase in MICs was noted between 24 and 48 h of incubation. On the other hand, the two methods used for MIC determination (visual and spectrophotometric readings) showed good agreement. These results suggest that the zygomycetes are a heterogeneous group for antifungal susceptibility. Some of the conventional and new antifungals are effective in vitro; their efficacies in vivo remain to be determined. The spectrophotometric method appears to be a valuable alternative to the visual method for MIC determination for zygomycetes.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 37 条
  • [1] Quality control limits for broth microdilution susceptibility tests of ten antifungal agents
    Barry, AL
    Pfaller, MA
    Brown, SD
    Espinel-Ingroff, A
    Ghannoum, MA
    Knapp, C
    Rennie, RP
    Rex, JH
    Rinaldi, MG
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) : 3457 - 3459
  • [2] Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis
    Dannaoui, E
    Mouton, JW
    Meis, JFGM
    Verweij, PE
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) : 1953 - 1959
  • [3] Use of spectrophotometric reading for in vitro antifungal susceptibility testing of Aspergillus spp.
    Dannaoui, E
    Persat, F
    Monier, MF
    Borel, E
    Piens, MA
    Picot, S
    [J]. CANADIAN JOURNAL OF MICROBIOLOGY, 1999, 45 (10) : 871 - 874
  • [4] In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens
    Espinel-Ingroff, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (01) : 198 - 202
  • [5] Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts
    Espinel-Ingroff, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) : 2950 - 2956
  • [6] COMPARISON OF 2 ALTERNATIVE MICRODILUTION PROCEDURES WITH THE NATIONAL-COMMITTEE-FOR-CLINICAL-LABORATORY-STANDARDS REFERENCE MACRODILUTION METHOD M27-P FOR IN-VITRO TESTING OF FLUCONAZOLE-RESISTANT AND FLUCONAZOLE-SUSCEPTIBLE ISOLATES OF CANDIDA-ALBICANS
    ESPINELINGROFF, A
    RODRIGUEZTUDELA, JL
    MARTINEZSUAREZ, JV
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (12) : 3154 - 3158
  • [7] COMPARATIVE AND COLLABORATIVE EVALUATION OF STANDARDIZATION OF ANTIFUNGAL SUSCEPTIBILITY TESTING FOR FILAMENTOUS FUNGI
    ESPINELINGROFF, A
    DAWSON, K
    PFALLER, M
    ANAISSIE, E
    BRESLIN, B
    DIXON, D
    FOTHERGILL, A
    PAETZNICK, V
    PETER, J
    RINALDI, M
    WALSH, T
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) : 314 - 319
  • [8] Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi
    EspinelIngroff, A
    Bartlett, M
    Bowden, R
    Chin, NX
    Cooper, C
    Fothergill, A
    McGinnis, MR
    Menezes, P
    Messer, SA
    Nelson, PW
    Odds, FC
    Pasarell, L
    Peter, J
    Pfaller, MA
    Rex, JH
    Rinaldi, MG
    Shankland, GS
    Walsh, TJ
    Weitzman, I
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (01) : 139 - 143
  • [9] Fung-Tomc JC, 1998, ANTIMICROB AGENTS CH, V42, P313
  • [10] TREATMENT OF MURINE PULMONARY MUCORMYCOSIS WITH SCH-42427, A BROAD-SPECTRUM TRIAZOLE ANTIFUNGAL DRUG
    GOLDANI, LZ
    SUGAR, AM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (02) : 369 - 372